Diabetes, Obesity and Metabolism, 1462-8902

Journal

More filtering options
  1. 2019
  2. Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults: Results from a 21-month randomized trial

    Hals, I. K., Fiskvik Fleiner, H., Reimers, N., Astor, M. C., Karin Filipsson, Ma, Z., Grill, V. & Björklund, A., 2019 May 30, In : Diabetes, Obesity and Metabolism.

    Research output: Contribution to journalArticle

  3. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study

    The SUMMIT consortium, Natali, A., Nesti, L., Venturi, E., Shore, A. C., Khan, F., Gooding, K., Gates, P. E., Looker, H. C., Dove, F., Isabel Goncalves, Margaretha Persson & Jan Nilsson, 2019 Feb, In : Diabetes, Obesity and Metabolism. 21, 2, p. 412-416

    Research output: Contribution to journalArticle

  4. 2018
  5. MicroRNAs in islet hormone secretion

    Jonathan L.S. Esguerra, Mototsugu Nagao, Jones K. Ofori, Anna Wendt & Lena Eliasson, 2018 Sep 1, In : Diabetes, Obesity and Metabolism. 20, Suppl 2, p. 11-19

    Research output: Contribution to journalReview article

  6. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

    Bo Ahrén, Atkin, S. L., Charpentier, G., Warren, M. L., Wilding, J. P. H., Birch, S., Holst, A. G. & Leiter, L. A., 2018 Sep 1, In : Diabetes, Obesity and Metabolism. 20, 9, p. 2210-2219 10 p.

    Research output: Contribution to journalArticle

  7. Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review

    Pearce, I., Simó, R., Monica Lövestam-Adrian, Wong, D. T. & Evans, M., 2018, In : Diabetes, Obesity and Metabolism.

    Research output: Contribution to journalReview article

  8. 2017
  9. Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

    Yabe, D., Eto, T., Shiramoto, M., Irie, S., Murotani, K., Seino, Y., Kuwata, H., Kurose, T., Seino, S., Bo Ahrén & Seino, Y., 2017, In : Diabetes, Obesity and Metabolism. 19, 3, p. 442-447

    Research output: Contribution to journalArticle

  10. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes

    Preiss, D., Dawed, A., Welsh, P., Heggie, A., Jones, A. G., Dekker, J., Robert Koivula, Hansen, T. H., Stewart, C., Holman, R. R., Paul W. Franks, Walker, M., Pearson, E. R. & Sattar, N., 2017, In : Diabetes, Obesity and Metabolism. 19, 3, p. 356-363

    Research output: Contribution to journalArticle

  11. 2016
  12. Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.

    Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A. & Bo Ahrén, 2016, In : Diabetes, Obesity and Metabolism. 18, 1, p. 24-33

    Research output: Contribution to journalArticle

  13. 2015
  14. The Islet and Metabolism Keep Time

    Thorens, B., Accili, D., Bo Ahrén, Cerasi, E., Seino, S. & Boitard, C., 2015, In : Diabetes, Obesity and Metabolism. 17, Suppl 1, p. 3-5

    Research output: Contribution to journalDebate/Note/Editorial

  15. 2014
  16. Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.

    Bo Ahrén, Gautier, J-F., Berria, R., Stager, W., Aronson, R. & Bailey, C. J., 2014, In : Diabetes, Obesity and Metabolism. 16, 9, p. 861-868

    Research output: Contribution to journalArticle

  17. The mind and the belly: a glance at how the nervous system directs metabolism

    Accili, D., Bo Ahrén, Boitard, C., Seino, S., Thorens, B. & Cerasi, E., 2014, In : Diabetes, Obesity and Metabolism. 16, p. 1-3

    Research output: Contribution to journalDebate/Note/Editorial

  18. 2013
  19. Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

    Monami, M., Bo Ahrén, Dicembrini, I. & Mannucci, E., 2013, In : Diabetes, Obesity and Metabolism. 15, 2, p. 112-120

    Research output: Contribution to journalArticle

  20. Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.

    Lena Ohlsson, Alsalim, W., Carr, R. D., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2013, In : Diabetes, Obesity and Metabolism. 15, 6, p. 531-537

    Research output: Contribution to journalArticle

  21. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    Nauck, M., Frid, A., Hermansen, K., Thomsen, A. B., During, M., Shah, N., Tankova, T., Mitha, I. & Matthews, D. R., 2013, In : Diabetes, Obesity and Metabolism. 15, 3, p. 204-212

    Research output: Contribution to journalArticle

  22. Shifting the paradigm of islet inflammation-good guy or bad guy?

    Bo Ahrén, Accili, D., Boitard, C., Cerasi, E., Thorens, B. & Seino, S., 2013, In : Diabetes, Obesity and Metabolism. 15, p. 4-9

    Research output: Contribution to journalDebate/Note/Editorial

  23. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    Alba, M., Bo Ahrén, Inzucchi, S. E., Guan, Y., Mallick, M., Xu, L., O'Neill, E. A., Williams-Herman, D. E., Kaufman, K. D. & Goldstein, B. J., 2013, In : Diabetes, Obesity and Metabolism. 15, 12, p. 1101-1110

    Research output: Contribution to journalArticle

  24. 2012
  25. The hyperstimulated beta-cell: prelude to diabetes?

    Boitard, C., Accili, D., Bo Ahrén, Cerasi, E., Seino, S. & Thorens, B., 2012, In : Diabetes, Obesity and Metabolism. 14, S3, p. iv-viii

    Research output: Contribution to journalDebate/Note/Editorial

  26. Using albumin to improve the therapeutic properties of diabetes treatments.

    Bo Ahrén & Burke, B., 2012, In : Diabetes, Obesity and Metabolism. 14, p. 121-129

    Research output: Contribution to journalArticle

  27. 2011
  28. Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)

    Lindblad, U., Lindberg, G., Månsson, N-O., Jonas Ranstam, Tyrberg, M., Jansson, S., Lindwall, K., Svärdh, M., Kindmalm, L. & Melander, A., 2011, In : Diabetes, Obesity and Metabolism. 13, 2, p. 185-188

    Research output: Contribution to journalArticle

  29. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.

    Bo Ahrén, Foley, J. E. & Bosi, E., 2011, In : Diabetes, Obesity and Metabolism. 13, 3, p. 193-203

    Research output: Contribution to journalArticle

  30. Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.

    Ola Lindgren, Carr, R., Holst, J. J., Deacon, C. & Bo Ahrén, 2011, In : Diabetes, Obesity and Metabolism. 13, p. 863-865

    Research output: Contribution to journalArticle

  31. Editorial: Long in the shade, glucagon re-occupies centre court

    Henquin, J. -C., Accili, D., Bo Ahrén, Boitard, C., Seino, S. & Cerasi, E., 2011, In : Diabetes, Obesity and Metabolism. 13, Suppl. 1, p. V-VIII

    Research output: Contribution to journalDebate/Note/Editorial

  32. Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.

    Alam, M., Van der Schueren, B. J., Bo Ahrén, Wang, G. C., Swerdlow, N. J., Arias, S., Bose, M., Gorroochurn, P., Teixeira, J., McGinty, J. & Laferrère, B., 2011, In : Diabetes, Obesity and Metabolism. 13, 4, p. 378-381

    Research output: Contribution to journalArticle

  33. Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.

    Bo Ahrén, Schweizer, A., Dejager, S., Villhauer, E. B., Dunning, B. E. & Foley, J. E., 2011, In : Diabetes, Obesity and Metabolism. 13, 9, p. 775-783

    Research output: Contribution to journalReview article

  34. The future of incretin-based therapy: novel avenues-novel targets.

    Bo Ahrén, 2011, In : Diabetes, Obesity and Metabolism. 13 Suppl 1, p. 158-166

    Research output: Contribution to journalArticle

  35. 2010
  36. A low glycaemic diet improves oral glucose tolerance but has no effect on β-cell function in C57BL/6J mice.

    Ulrika Axling, Rosén, L., Nils Wierup, Östman, E., Björck, I. & Cecilia Holm, 2010, In : Diabetes, Obesity and Metabolism. 12, 11, p. 976-982

    Research output: Contribution to journalArticle

  37. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

    Matthews, D. R., Dejager, S., Bo Ahrén, Fonseca, V., Ferrannini, E., Couturier, A., Foley, J. E. & Zinman, B., 2010, In : Diabetes, Obesity and Metabolism. 12, 9, p. 780-789

    Research output: Contribution to journalArticle

  38. What ails the beta-cell?

    Accili, D., Bo Ahrén, Boitard, C., Cerasi, E., Henquin, J. -C. & Seino, S., 2010, In : Diabetes, Obesity and Metabolism. 12, p. 1-3

    Research output: Contribution to journalDebate/Note/Editorial

  39. 2009
  40. beta-Cell research - A decade of rapid growth

    Bo Ahrén, Accili, D., Boitard, C., Efendic, S., Henquin, J-C., Seino, S., Steiner, D. F. & Cerasi, E., 2009, In : Diabetes, Obesity and Metabolism. 11, p. IV-IX

    Research output: Contribution to journalArticle

  41. Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery

    Guldstrand, M., Bo Ahrén, Naslund, E., Holst, J. J. & Adamson, U., 2009, In : Diabetes, Obesity and Metabolism. 11, 11, p. 1027-1033

    Research output: Contribution to journalArticle

  42. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

    Lund, S. S., Tarnow, L., Astrup, A. S., Hovind, P., Jacobsen, P. K., Alibegovic, A. C., Parving, I., Pietraszek, L., Frandsen, M., Rossing, P., Parving, H. -H. & Allan Vaag, 2009, In : Diabetes, Obesity and Metabolism. 11, 10, p. 966-977

    Research output: Contribution to journalArticle

  43. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

    Ferrannini, E., Fonseca, V., Zinman, B., Matthews, D., Bo Ahrén, Byiers, S., Shao, Q. & Dejager, S., 2009, In : Diabetes, Obesity and Metabolism. 11, 2, p. 157-166

    Research output: Contribution to journalArticle

  44. Functional SOCS1 polymorphisms are associated with variation in obesity in whites

    Gylvin, T., Ek, J., Nolsoe, R., Albrechtsen, A., Andersen, G., Bergholdt, R., Brorsson, C., Bang-Berthelsen, C. H., Hansen, T., Karlsen, A. E., Billestrup, N., Borch-Johnsen, K., Jorgensen, T., Pedersen, O., Mandrup-Poulsen, T., Nerup, J. & Pociot, F., 2009, In : Diabetes, Obesity and Metabolism. 11, 3, p. 196-203

    Research output: Contribution to journalArticle

  45. Genetic basis of beta-cell dysfunction in man.

    Leif Groop & Valeriya Lyssenko, 2009, In : Diabetes, Obesity and Metabolism. 11 Suppl 4, p. 149-158

    Research output: Contribution to journalArticle

  46. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data

    Brorsson, C., Hansen, N. T., Lage, K., Bergholdt, R., Brunak, S. & Pociot, F., 2009, In : Diabetes, Obesity and Metabolism. 11, S1, p. 60-66

    Research output: Contribution to journalArticle

  47. Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.

    Vikman, J. & Bo Ahrén, 2009, In : Diabetes, Obesity and Metabolism. 11 Suppl 4, p. 197-201

    Research output: Contribution to journalArticle

  48. 2008
  49. Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up

    Alvarsson, M., Sundkvist, G., Lager, I., Kerstin Berntorp, Fernqvist-Forbes, E., Steen, L., Örn, T., Holberg, M. A., Kirksaether, N. & Grill, V., 2008, In : Diabetes, Obesity and Metabolism. 10, 5, p. 421-429

    Research output: Contribution to journalArticle

  50. Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Jauffret, S. & Foley, J. E., 2008, In : Diabetes, Obesity and Metabolism. 10, 8, p. 675-682

    Research output: Contribution to journalArticle

  51. Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Wang, Y., Dunning, B. E. & Foley, J. E., 2008, In : Diabetes, Obesity and Metabolism. 10, 11, p. 1114-1124

    Research output: Contribution to journalArticle

  52. Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report

    Tyrberg, M., Melander, A., Monica Lövestam Adrian & Lindblad, U., 2008, In : Diabetes, Obesity and Metabolism. 10, 8, p. 646-651

    Research output: Contribution to journalArticle

  53. 2007
  54. Prediction of fat-free body mass from bioelectrical impedance among 9-to 11-year-old Swedish children

    Nielsen, B. M., Magnus Dencker, Ward, L., Christian Lindén, Ola Thorsson, Magnus Karlsson & Heitmann, B. L., 2007, In : Diabetes, Obesity and Metabolism. 9, 4, p. 521-539

    Research output: Contribution to journalArticle

  55. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial

    Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Frandsen, M., Smidt, U. M., Pedersen, O., Parving, H. -H. & Allan Vaag, 2007, In : Diabetes, Obesity and Metabolism. 9, 3, p. 394-407

    Research output: Contribution to journalArticle

  56. 2006
  57. 2005
Previous 1 2 Next